Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
METAOD001: A Phase I (double-blind, placebo-controlled, dose escalation) safety study with doses (ranging from 25 to 400 g/kg AOD9604) administered intravenously to 15 healthy adult male volunteers presenting with a BMI between 24 and 30 kg/m 2
This peptide is for research purposes only and is not intended for human administration
We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process
BPC-157 shows potential in various conditions and injuries, making it valuable for research
Similar content being viewed by others Introduction The broad adoption of electronic health record (EHR) systems has created unprecedented resources and opportunities for conducting health informatics research
They tell payers what kind of institution is filing the claim, what type of care was provided, and where this claim falls within the patients episode of care
US$ 29.30
US$ 24.09
US$ 23.97
US$ 26.46
US$ 27.35
US$ 25.37
